T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Regenxbio
RGNX
$701M
| $185K | ﹤0.01% |
23,910
+1,982
| +9% | +$18.6K |
|
2702
Beyond Meat
BYND
$219M
| $184K | ﹤0.01% |
48,897
+14,048
| +40% | +$74.6K |
|
|
FNA
2703
DELISTED
Paragon 28, Inc.
FNA
| $184K | ﹤0.01% |
17,786
+2,618
| +17% | +$21.1K |
|
2704
eHealth
EHTH
$39.7M
| $183K | ﹤0.01% |
19,400
| – | – |
|
2705
Stereotaxis
STXS
$136M
| $183K | ﹤0.01% |
80,012
+3,813
| +5% | +$7.97K |
|
2706
SkinHealth Systems
SKIN
$84.8M
| $182K | ﹤0.01% |
114,147
+18,400
| +19% | +$28.9K |
|
2707
TTEC Holdings
TTEC
$78.4M
| $182K | ﹤0.01% |
36,443
+6,273
| +21% | +$32.8K |
|
2708
NewtekOne
NEWT
$381M
| $181K | ﹤0.01% |
14,115
+2,633
| +23% | +$35.7K |
|
2709
Real Brokerage
REAX
$499M
| $181K | ﹤0.01% |
39,319
+7,159
| +22% | +$37.5K |
|
2710
iHeartMedia
IHRT
$469M
| $180K | ﹤0.01% |
90,745
-34,430
| -28% | -$72.9K |
|
2711
Nektar Therapeutics
NKTR
$2.57B
| $180K | ﹤0.01% |
12,865
+729
| +6% | +$12.9K |
|
|
INVX
2712
Innovex International
INVX
$2.15B
| $180K | ﹤0.01% |
12,880
+1,909
| +17% | +$28.6K |
|
2713
Groupon
GRPN
$884M
| $179K | ﹤0.01% |
14,652
+1,552
| +12% | +$16.3K |
|
|
SELF
2714
Global Self Storage
SELF
$59M
| $179K | ﹤0.01% |
33,399
| – | – |
|
2715
Stem
STEM
$54.5M
| $179K | ﹤0.01% |
14,902
| – | – |
|
2716
BigBear.ai
BBAI
$1.58B
| $178K | ﹤0.01% |
39,966
+7,177
| +22% | +$16.2K |
|
2717
National CineMedia
NCMI
$243M
| $178K | ﹤0.01% |
26,749
+4,084
| +18% | +$28.1K |
|
2718
MaxCyte
MXCT
$160M
| $177K | ﹤0.01% |
42,356
+8,951
| +27% | +$33.8K |
|
2719
Erasca
ERAS
$6.34B
| $176K | ﹤0.01% |
70,037
+10,899
| +18% | +$29.9K |
|
2720
Lindblad Expeditions
LIND
$2.25B
| $176K | ﹤0.01% |
14,762
+3,381
| +30% | +$38.8K |
|
|
AGS
2721
DELISTED
PlayAGS
AGS
| $175K | ﹤0.01% |
15,171
+2,582
| +21% | +$29.9K |
|
2722
Smith & Wesson
SWBI
$644M
| $175K | ﹤0.01% |
17,310
+2,518
| +17% | +$31.5K |
|
2723
Ardagh Metal Packaging
AMBP
$3.14B
| $174K | ﹤0.01% |
57,588
+10,729
| +23% | +$38.6K |
|
|
FIRY
2724
Firy Inc
FIRY
$158M
| $174K | ﹤0.01% |
34,592
| – | – |
|
2725
UWM Holdings
UWMC
$2.6B
| $174K | ﹤0.01% |
29,477
+3,524
| +14% | +$22.9K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.